Clinical Trials

Evaluation of the Safety and Efficacy of Treatment w/ High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/ Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/ Liver Dominant Disease

ClinicalTrials.gov ID: NCT06875128
Last updated: 2025-05-22

Learn more

Evaluation of the Safety and Efficacy of Treatment w/ High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/ approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/ liver Dominant Disease

ClinicalTrials.gov ID: NCT06607458
Last updated: 2024-09-23

Learn more

Active Clinical Trial Sites by Study

Delcath continues to expand its clinical trial network across leading academic and cancer centers in the United States and Europe. The sites listed below are currently activated for our ongoing studies.

Metastatic Breast Cancer (MBC)

ClinicalTrials.gov ID: NCT06875128

United States

  • Moffitt Cancer Center (Tampa, FL)

  • Ohio State University, Stefanie Spielman Comprehensive Breast Center (Columbus, OH)

Metastatic Colorectal Cancer (CRC)

ClinicalTrials.gov ID: NCT06607458

United States

  • City of Hope (Duarte, CA)
  • University of Kansas Medical Center (Kansas City, KS)
  • Moffitt Cancer Center (Tampa, FL)
  • UCLA (Los Angeles, CA)
  • Huntsman Cancer Institute (Salt Lake City, UT)

Europe

  • Clinic Barcelona (Barcelona, Spain)
  • Helios Park-Klinikum Leipzig (Leipzig, Germany)
  • IEO Milan (Milan, Italy)
  • University Hospital (Czechia)
  • Clinical Hospital Center “Bezanijska kosa” (Belgrade, Serbia)

    Additional sites may be added as they complete activation.